Graviton BioScience Announces Clearance of Investigational New Drug (IND) for GV101 for the Treatment of Friedreich's Ataxia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. BRZE
2. TTAN
3. CHYM
4. USO
5. QCOM
6. IRT
7. ASO
8. NTHI
9. SPY
10. EVMN

Go back to Graviton BioScience Announces Clearance of Investigational New Drug (IND) for GV101 for the Treatment of Friedreich's Ataxia
(NASDAQ: MGTX) Delayed: 13.47 -0.06 (0.44%)
Previous Close $13.53    52 Week High $ 
Open $13.40    52 Week Low $ 
Day High $13.76    P/E N/A 
Day Low $13.40    EPS $ 
Volume 170,598